
Opinion|Videos|February 4, 2026
Amy Luckenbaugh, MD, reflects on patient resilience, GU oncology advances for World Cancer Day
Author(s)Amy N. Luckenbaugh, MD
Fact checked by: Hannah Clarke
Amy N. Luckenbaugh, MD, FACS, shares what her patients have taught her about resilience as well as some of the advances in urologic oncology that are giving her hope.
Advertisement
In recognition of World Cancer Day on February 4, 2026, Amy N. Luckenbaugh, MD, FACS, shares what her patients have taught her about resilience as well as some of the advances in urologic oncology that are giving her hope. Luckenbaugh is a urologic oncology at Vanderbilt University Medical Center in Nashville, Tennessee.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Ravi Munver, MD, highlights study of first- and second-generation Aquablation systems
2
EV plus pembro approval reframes first conversation in MIBC diagnosis
3
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
4
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
5












